WA
ABVX

WPG Advisers’s Abivax ABVX Stock Holding History

WPG Advisers’s Portfolio ABVX Stock Details ABVX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$57.6K Sell
432
-40
-8% -$4.53K 0.03% 277
2026
Q1 		$52.6K Buy
472
+18
+4% +$2.13K 0.04% 275
2025
Q4 		$61.2K Buy
454
+253
+126% +$27.6K 0.05% 249
2025
Q3 		$17.1K Buy
+201
New +$12.3K 0.01% 542

Other funds holding ABVX

NNPTE
Nationale-Nederlanden Powszechne Towarzystwo Emerytalne Warszawa, Poland $1.83B AUM 331.52% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
NFT
Nan Fung Trinity Central, Hong Kong, Hong Kong $1.01B AUM 64.38% 1-Year Est. Return
ACL
APEIRON Capital Ltd Hong Kong $156M AUM 183.17% 1-Year Est. Return
TCM
TimesSquare Capital Management New York $6.8B AUM 45.85% 1-Year Est. Return
ACM
ACT Capital Management Wayne, Pennsylvania $153M AUM

WPG Advisers's ABVX Position: Q2 2026 in Review

WPG Advisers reduced its Abivax (ABVX) stake by 8.5% in Q2 2026, selling an estimated $4.53K and leaving 432 shares worth $57.6K. The position accounts for 0.03% of the portfolio, ranked #277.

WPG Advisers first reported a position in ABVX in Q3 2025 and has held it in 4 quarters since. The position peaked at $61.2K in Q4 2025. 105 funds tracked by Wall St. Rank hold ABVX as of Q2 2026.

  • WPG Advisers held 432 shares of Abivax worth $57.6K as of Q2 2026.
  • WPG Advisers sold 40 Abivax shares in Q2 2026, an estimated $4.53K.
  • Abivax made up 0.03% of WPG Advisers's portfolio in Q2 2026, its #277 holding.
  • WPG Advisers first reported a position in Abivax in Q3 2025 and has held it in 4 quarters since.
  • WPG Advisers's Abivax position peaked at $61.2K in Q4 2025.
  • 105 funds tracked by Wall St. Rank held Abivax as of Q2 2026.

Based on WPG Advisers's 13F filing for Q2 2026, filed 6 Aug 2026.